Exploring the evolution of clinical operations from paper to digital era, Emma Earl shares insights on career advancements in the tech-driven pharmaceutical industry. Highlighting the importance of efficient systems and data management, the podcast delves into the benefits of transitioning to CTMS and balancing scientific research with operational needs.

Chris Moore, President of Veeva Europe, shares his insights on the evolving landscape of clinical trials in the U.K. and Europe. He discusses the recent government efforts to revitalize the U.K. life sciences sector, detailing the impact of Brexit and COVID-19. Moore emphasizes the need for improved technology in clinical trial processes, addressing challenges like data fragmentation. He also explores the European Commission's initiatives for a unified medicines market and the potential of AI to enhance efficiency and access in healthcare.

Patrick Nadolny, Global Head of Clinical Data Management at Sanofi, discusses the future of EDC, new programs at Sanofi, and the need for a patient-driven trial model. They explore the evolving landscape of clinical data management, the impact and challenges of data management in clinical trials, and the importance of simplifying processes and partnering with technology providers for solutions. They also emphasize the need for continued experimentation and rethinking strategies in clinical data innovation.

Jim Reilly, Veeva's VP of Development Cloud Strategy, joins Richard Young to discuss their takeaways from Veeva's recent North American R&D and Quality Summit. They talk about patient centricity, the future of digital trials, and major updates from Veeva announced at the event.

Does ChatGPT understand clinical trials? This week, Richard Young speaks to Andy Cooper, CEO of CluePoints, about going beyond the buzzword and making AI a reality in clinical data management. They discuss how to approach these technologies today and how to identify the areas of clinical trials where AI will be the most useful. Andy also deep dives on the different types of machine learning, how to train and develop trust with these tools, and why industry context is key when using AI-powered tools.  Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk Veeva website: https://go.veeva.com/l/28972/2023-08-22/9p7245

This week, Richard Young speaks to Tim Davis, vice president of strategy for MyVeeva for Patients. In recent years, decentralized clinical trials, patient centricity, and site centricity have become buzzwords for sponsors and CROs. This episode covers how to cut through the hype and focus on ideas that would both impact patient lives and make things easier for sites. As Tim explains, positive change starts with expanding patient choice during clinical trials. Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Rhona O’Donnell, VP, Data Management Systems and Standards, Novo Nordisk This week, Richard Young is joined by Rhona O’Donnell, VP, Data Management Systems and Standards at Novo Nordisk. They discuss the evolution of the data management role, and how we can prepare for the future through collaboration and more effective training for the next generation. Richard and Rhona share their thoughts on the growing list of responsibilities facing data managers; why risk-based data management can help make trials more sustainable; the largest opportunities for time savings within the data management world; and the big initiatives that Novo Nordisk is working on to improve their data management processes.  Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk

This week, Richard Young speaks to Alan Morgan, CEO Advisor of Excelya. In recent years, sponsors and CROs have invested heavily in “big data” tools for site selection and productivity. But, has that investment paid off? Richard and Alan discuss whether we’ve come any closer to truly patient-centric trials – and what we still have left to do. From partnering with patient advocacy groups to going back to the basics on data management, this episode covers some new industry initiatives that could make a positive difference for patients. Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Luis E. Torres, Head of Clinical Programming FSPx, Labcorp This week, Richard Young speaks to Luis E. Torres, head of Clinical Programming FSPx at LabCorp. They discuss how data managers can prepare for the future of clinical trials by adopting new technologies and skills to keep decentralized clinical teams connected. Richard and Luis share their thoughts on designing studies and processes that support end-user needs; the shifting goal posts of data cleanliness and database build expectations; and why data managers are uniquely positioned to solve the “Rubik’s Cube” of challenges involving people, processes, and technology. Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Mayank Anand, VP and Global Head of Data Strategy and Management, GSK In this week’s conversation, Richard Young and Mayank Anand, global head of data strategy and management at GSK and Chair of SCDM, discuss how clinical data professionals’ roles are evolving in a world of decentralized data. It’s a great time to be a clinical data professional, they agree, as a once invisible role moves front and center to optimize trial protocols, operations, and results, and speed patient access to better treatments. SCDM offers professionals a global voice and a forum for discussion and debate, and Mayank summarizes the organization’s key goals. Both Richard and Mayank share insights into understanding end user and patient needs; balancing the needs of different stakeholders; and solving a Rubik’s cube of challenges that involve people, processes, and technology. Mayank also shows how new perspectives are driving a more inclusive strategy and collaborative mindset that is already improving patient focus and business results at GSK and within the industry. Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.